85
|
306
|
8styA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi60 |
84
|
302
|
8aj0AAA |
Mpro of sars cov-2 in complex with the rk-90 inhibitor |
80
|
301
|
8fivA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun10541r |
88
|
305
|
8ifrA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 3 |
85
|
305
|
8igxA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 9 (simnotrelvir, sim0417, ssd8432) |
83
|
300
|
8ifsA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 7 |
88
|
305
|
8ifpA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 1 |
88
|
305
|
8ifqA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 2 |
88
|
306
|
8iftA |
Sars-cov-2 3cl protease (3clpro) in complex with compound 10 |
92
|
305
|
8igyA |
Sars-cov-2 3cl protease (3clpro) in complex with nirmatrelvir |
90
|
306
|
8f2dA |
Sars-cov-2 main protease (mpro) in complex with ml4006a |
93
|
306
|
8ezvA |
Sars-cov-2 main protease (mpro) in complex with ml2006a |
90
|
306
|
8ezzA |
Sars-cov-2 main protease (mpro) in complex with ml2006a2 |
83
|
300
|
8hi9A |
Sars-cov-2 3cl protease (3clpro) in complex with robinetin |
88
|
306
|
8h5fA |
Crystal structure of sars-cov-2 main protease (mpro) l167f mutant in complex with inhibitor nirmatrelvir |
84
|
301
|
8h6iA |
The crystal structure of sars-cov-2 3c-like protease double mutant (l50f and e166v) in complex with a traditional chinese medicine inhibitors |
86
|
306
|
8h5pA |
Crystal structure of sars-cov-2 main protease (mpro) double mutant (l50f and e166v) in complex with inhibitor nirmatrelvir |
85
|
302
|
8h7kA |
Sars-cov-2 mpro double mutant (h41a and t21i) in complex with nsp4/5 peptidyl substrate |
87
|
306
|
8h4yA |
Crystal structure of sars-cov-2 main protease (mpro) f140l mutant in complex with inhibitor nirmatrelvir |
93
|
306
|
8h82A |
Crystal structure of sars-cov-2 main protease (mpro) mutant (e166v) in complex with protease inhibitor nirmatrelvir |
87
|
306
|
8h51A |
Crystal structure of sars-cov-2 main protease (mpro) double mutant (t21i and e166v) in complex with inhibitor nirmatrelvir |
87
|
302
|
8h3kA |
Crystal structure of sars-cov-2 main protease (mpro) double mutant (l50f and e166v) in complex with inhibitor enstrelvir |
89
|
302
|
8h3gA |
Crystal structure of sars-cov-2 main protease (mpro) e166v mutant in complex with inhibitor enstrelvir |
88
|
305
|
8h7wA |
Crystal structure of sars-cov-2 main protease (mpro) mutant (s144a) in complex with protease inhibitor nirmatrelvir |
0
|
10
|
8h7kB |
Sars-cov-2 mpro double mutant (h41a and t21i) in complex with nsp4/5 peptidyl substrate |
90
|
306
|
8h57A |
Crystal structure of sars-cov-2 main protease (mpro) a193p mutant in complex with inhibitor nirmatrelvir |
90
|
306
|
8f2cA |
Sars-cov-2 main protease (mpro) in complex with ml3006a |
90
|
306
|
8f02A |
Sars-cov-2 main protease (mpro) in complex with ml2006a4 |
85
|
302
|
8h3lA |
Crystal structure of sars-cov-2 main protease (mpro) double mutant (t21i and e166v) in complex with inhibitor enstrelvir |
86
|
300
|
8hbkA |
The crystal structure of sars-cov-2 3cl protease in complex with ensitrelvir |
90
|
306
|
8h6nA |
Crystal structure of sars-cov-2 main protease (mpro) mutant (t21i) in complex with protease inhibitor nirmatrelvir |
89
|
306
|
8bgdA |
Structure of mpro from sars-cov-2 in complex with fga147 |
86
|
305
|
8bgaA |
Structure of mpro in complex with fga146 |
88
|
305
|
8bfoA |
Structure of the apo form of mpro from sars-cov-2 |
85
|
306
|
8bfqA |
Structure of the apo form of mpro from sars-cov-2 |
88
|
305
|
7uupA |
Sars-cov-2 main protease s144a (mpro s144a) in complex with nirmatrelvir (pf-07321332) |
90
|
306
|
7uugA |
Sars-cov-2 main protease s144a (mpro s144a) in complex with ml1006a |
76
|
302
|
8jopA |
Crystal structure of the sars-cov-2 main protease in complex with 11a |
86
|
306
|
8aivAAA |
Mpro of sars cov-2 in complex with the mg-100 inhibitor |
86
|
304
|
8i30A |
Crystal structure of the sars-cov-2 main protease in complex with 32j |
85
|
305
|
8aiuAAA |
Mpro of sars cov-2 in complex with the mg-97 inhibitor |
84
|
302
|
8fiwA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun10221 |
80
|
301
|
8b56A |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the inhibitor gd-9 |
86
|
306
|
8tbeA |
Co-crystal structure of sars-cov-2 mpro with pomotrelvir |
88
|
303
|
8gxhA |
The crystal structure of sars-cov-2 main protease in complex with 14b |
88
|
302
|
8gxgA |
The crystal structure of sars-cov-2 main protease in complex with 14a |
86
|
302
|
8gxiA |
The crystal structure of sars-cov-2 main protease in complex with 14c |
77
|
301
|
8gzbA |
Sars-cov-2 3clpro |
74
|
299
|
8sg6A |
Sars-cov-2 main protease (mpro) h163a mutant reduced with 20mm tcep |
90
|
300
|
7wqbA |
Sars-cov-2 main protease mutant (p168a) in complex with mg-132 |